Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Dawson James Downgrades BioCardia to Neutral

Dawson James Downgrades BioCardia to Neutral

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

Analyst Ratings

What 4 Analyst Ratings Have To Say About SEMrush Hldgs

By Benzinga Insights

July 20, 11:00 AM

Within the last quarter, SEMrush Hldgs (NYSE:SEMR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

SEMR

UiPath Analysts See It Improving Value By Its Platform Strategy

By Anusuya Lahiri

September 28, 2:59 PM

Analysts attended UiPath, Inc's (NYSE: PATH) annual analyst day yesterday.

PATH

Galaxy Digital Subsidiary Gets Regulatory Approval To Set Up Shop In The Bahamas

By Murtuza Merchant

February 13, 3:59 PM

Galaxy Bahamas, a subsidiary of Galaxy Digital, Mike Novogratz's crypto investment firm, has recently received regulatory approval to operate in the Bahamas.

$BUSD

Hedge Fund Manager Buys Tesla Stock After ‘ChatGPT Moment’ With Latest Full Self-Driving Release: ‘Feels Like A Human Driving’

By Adam Eckert

March 27, 4:33 PM

On CNBC's "Fast Money Halftime Report," Brad Gerstner said that when everyone else is negative about a stock, he gets excited.

AAPL

Dawson James Downgrades BioCardia to Neutral

Related Posts

What 4 Analyst Ratings Have To Say About SEMrush Hldgs

UiPath Analysts See It Improving Value By Its Platform Strategy

Galaxy Digital Subsidiary Gets Regulatory Approval To Set Up Shop In The Bahamas

Hedge Fund Manager Buys Tesla Stock After ‘ChatGPT Moment’ With Latest Full Self-Driving Release: ‘Feels Like A Human Driving’